Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
2020 · Cell · 446 citations
https://doi.org/10.1016/j.cell.2020.06.001
S
Stephanie K. Dougan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
308
Papers
10.6K
Citations
51
h-index
90
i10-index
Stephanie K. Dougan is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Pancreatic and Hepatic Oncology Research & Immune Cell Function and Interaction. The author has an h-index of 51, co-authored 262 publications.
ORCID: 0000-0002-2263-363XPapers by this author
worksEosinophils in Health and Disease: A State-of-the-Art Review
2021 · Mayo Clinic Proceedings · 297 citations
https://doi.org/10.1016/j.mayocp.2021.04.025
Immune mechanisms of toxicity from checkpoint inhibitors
2023 · Trends in cancer · 217 citations
https://doi.org/10.1016/j.trecan.2023.04.002
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
2024 · Cancer Discovery · 196 citations
https://doi.org/10.1158/2159-8290.cd-24-0177
Cytokines in cancer
2024 · Cancer Cell · 127 citations
https://doi.org/10.1016/j.ccell.2024.11.011
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 · Nature Biotechnology · 73 citations
https://doi.org/10.1038/s41587-022-01510-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat